Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine. more
Time Frame | IDXX | Sector | S&P500 |
---|---|---|---|
1-Week Return | 0.61% | -1.8% | -0.77% |
1-Month Return | -0.05% | -3.48% | 0.71% |
3-Month Return | -10.85% | -7.2% | 8.81% |
6-Month Return | -13.65% | -1.54% | 12.32% |
1-Year Return | -18.47% | 8.39% | 30.57% |
3-Year Return | -27.8% | 6.07% | 29.21% |
5-Year Return | 74.52% | 44.07% | 91.95% |
10-Year Return | 486.29% | 106.3% | 196.04% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 2.41B | 2.71B | 3.22B | 3.37B | 3.66B | [{"date":"2019-12-31","value":65.75,"profit":true},{"date":"2020-12-31","value":73.93,"profit":true},{"date":"2021-12-31","value":87.83,"profit":true},{"date":"2022-12-31","value":91.98,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 1.04B | 1.14B | 1.33B | 1.36B | 1.47B | [{"date":"2019-12-31","value":70.79,"profit":true},{"date":"2020-12-31","value":77.2,"profit":true},{"date":"2021-12-31","value":90.14,"profit":true},{"date":"2022-12-31","value":92.66,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 1.37B | 1.57B | 1.89B | 2.00B | 2.19B | [{"date":"2019-12-31","value":62.35,"profit":true},{"date":"2020-12-31","value":71.74,"profit":true},{"date":"2021-12-31","value":86.28,"profit":true},{"date":"2022-12-31","value":91.52,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 56.73% | 58.04% | 58.76% | 59.52% | 59.82% | [{"date":"2019-12-31","value":94.84,"profit":true},{"date":"2020-12-31","value":97.03,"profit":true},{"date":"2021-12-31","value":98.23,"profit":true},{"date":"2022-12-31","value":99.5,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Expenses | 812.70M | 876.52M | 957.40M | 1.11B | 1.09B | [{"date":"2019-12-31","value":73.51,"profit":true},{"date":"2020-12-31","value":79.28,"profit":true},{"date":"2021-12-31","value":86.6,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":98.85,"profit":true}] |
Operating Income | 552.85M | 694.52M | 932.03M | 898.76M | 1.10B | [{"date":"2019-12-31","value":50.39,"profit":true},{"date":"2020-12-31","value":63.3,"profit":true},{"date":"2021-12-31","value":84.95,"profit":true},{"date":"2022-12-31","value":81.92,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (61.26M) | (65.08M) | (58.75M) | (77.59M) | (79.58M) | [{"date":"2019-12-31","value":-6125600000,"profit":false},{"date":"2020-12-31","value":-6507800000,"profit":false},{"date":"2021-12-31","value":-5874800000,"profit":false},{"date":"2022-12-31","value":-7758600000,"profit":false},{"date":"2023-12-31","value":-7958200000,"profit":false}] |
Pre-Tax Income | 522.22M | 661.99M | 902.65M | 859.97M | 1.06B | [{"date":"2019-12-31","value":49.21,"profit":true},{"date":"2020-12-31","value":62.38,"profit":true},{"date":"2021-12-31","value":85.06,"profit":true},{"date":"2022-12-31","value":81.04,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | 94.43M | 79.85M | 157.81M | 180.88M | 216.13M | [{"date":"2019-12-31","value":43.69,"profit":true},{"date":"2020-12-31","value":36.95,"profit":true},{"date":"2021-12-31","value":73.01,"profit":true},{"date":"2022-12-31","value":83.69,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income After Taxes | 427.79M | 582.13M | 744.84M | 679.09M | 845.04M | [{"date":"2019-12-31","value":50.62,"profit":true},{"date":"2020-12-31","value":68.89,"profit":true},{"date":"2021-12-31","value":88.14,"profit":true},{"date":"2022-12-31","value":80.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Continuous Operations | 427.79M | 582.13M | 744.84M | 679.09M | 822.73M | [{"date":"2019-12-31","value":52,"profit":true},{"date":"2020-12-31","value":70.76,"profit":true},{"date":"2021-12-31","value":90.53,"profit":true},{"date":"2022-12-31","value":82.54,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 427.72M | 581.78M | 744.85M | 679.09M | 845.04M | [{"date":"2019-12-31","value":50.62,"profit":true},{"date":"2020-12-31","value":68.85,"profit":true},{"date":"2021-12-31","value":88.14,"profit":true},{"date":"2022-12-31","value":80.36,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
EPS (Diluted) | 4.88 | 6.71 | 8.61 | 8.03 | 10.07 | [{"date":"2019-12-31","value":48.46,"profit":true},{"date":"2020-12-31","value":66.63,"profit":true},{"date":"2021-12-31","value":85.5,"profit":true},{"date":"2022-12-31","value":79.74,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
IDXX | |
---|---|
Cash Ratio | 0.31 |
Current Ratio | 1.42 |
Quick Ratio | 1.03 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
IDXX | |
---|---|
ROA (LTM) | 22.79% |
ROE (LTM) | 59.42% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
IDXX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.52 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.48 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
IDXX | |
---|---|
Trailing PE | 42.93 |
Forward PE | 39.84 |
P/S (TTM) | 9.60 |
P/B | 22.81 |
Price/FCF | 192 |
EV/R | 9.78 |
EV/Ebitda | 30.03 |
PEG | 4.74 |
IDEXX Laboratories Inc (IDXX) share price today is $437.08
Yes, Indians can buy shares of IDEXX Laboratories Inc (IDXX) on Vested. To buy IDEXX Laboratories Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in IDXX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of IDEXX Laboratories Inc (IDXX) via the Vested app. You can start investing in IDEXX Laboratories Inc (IDXX) with a minimum investment of $1.
You can invest in shares of IDEXX Laboratories Inc (IDXX) via Vested in three simple steps:
The 52-week high price of IDEXX Laboratories Inc (IDXX) is $583.39. The 52-week low price of IDEXX Laboratories Inc (IDXX) is $398.5.
The price-to-earnings (P/E) ratio of IDEXX Laboratories Inc (IDXX) is 42.9266
The price-to-book (P/B) ratio of IDEXX Laboratories Inc (IDXX) is 22.81
The dividend yield of IDEXX Laboratories Inc (IDXX) is 0.00%
The market capitalization of IDEXX Laboratories Inc (IDXX) is $36.90B
The stock symbol (or ticker) of IDEXX Laboratories Inc is IDXX